Subhash
Kukreja, MD
Professor
of Medicine
Interim Section Chief
Phone: 312/996-6060
E-mail: skukreja@uic.edu
Education:
Board certification:
Internal Medicine, Endocrinology
Medical School:
New Delhi Medical School, India
Residency: Internal medicine, Cook County
Hospital
Fellowship: Endocrinology, University of Illinois
Clinical
interests:
Osteoporosis,
Metabolic bone disease
Invited
lectures:
Paget's disease update
Corticosteroid-induced osteoporosis
Osteoporosis
update
Male osteoporosis
Osteoporosis cases
Staying up to date (continuing
medical education):
Endocrine Society Meeting
American Society for Bone
and Mineral Research
Medicine Grand Rounds, University of Illinois
Endocrinology
Grand Rounds, University of Illinois
Research interests:
PTHrP, Bone tumors, Osteoporosis
Research studies:
1. Role of PTHrP in the
pathogenesis of prostate cancer: the effect of exogenous PTHrP and PTHrP transfection
on proliferation and apoptosis in prostate cancer cells.
Recent
Publications:
1. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma
S, Alekel L, Hasler CM, Drum ML, Hollis BW, Kukreja SC. Bone-sparing effect of
soy protein in ovarian hormone-deficient rats is related to its isoflavone content.
Am J Clin Nutr 68:1364S-1368S, 1998
2. Arjmandi BH, Getlinger MJ, Goyal NV,
Alekel L, Hasler CM, Juma S, Drum ML, Hollis BW, Kukreja SC. Role of soy protein
with normal or reduced isoflavone content in reversing bone loss induced by ovarian
hormone deficiency in rats. Am J Clin Nutr:68:1358S-1363S, 1998.
3. Alekel
DL,Mortillaro E, Hussain EA,West B, Ahmed N, Peterson CT, Werner RK, Arjmandi
BH, Kukreja SC. Lifestyle and biologic contributors to proximal femoral bone mineral
density and hip axis length in two distinct ethnic groups of women. Osteoporosis
Int. 9:327-338,1999
4. Arjmandi BH, Birnbaum RS, Juma S, Barengolts E, Kukreja
SC. The synthetic phytoestrogen, ipriflavone, and estrogen prevent bone loss by
different mechanisms.Cacif.Tissue Int. 66:61-65, 2000.
